Weighing in on Type 2 Diabetes Remission

Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial

(2021) Geltrude Mingrone et al.   LANCET

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

(2021) Melanie Davies et al.   LANCET

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019

(2021) Rozalina G. McCoy et al.   JAMA Network Open

Minimum Threshold of Bariatric Surgical Weight Loss for Initial Diabetes Remission

(2021) Douglas Barthold et al.   DIABETES CARE

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes

(2021) Matthew C. Riddle et al.   DIABETES CARE

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

(2021) Julio Rosenstock et al.   LANCET

Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial

(2020) Shahrad Taheri et al.   Lancet Diabetes & Endocrinology

Benefits and Risks of Bariatric Surgery in Adults

(2020) David E. Arterburn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes

(2020) Mihoko Yoshino et al.   NEW ENGLAND JOURNAL OF MEDICINE

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

(2019) Michael E J Lean et al.   Lancet Diabetes & Endocrinology

The effects of bariatric surgery on islet function, insulin secretion, & glucose control

(2019) Jonathan D Douros et al.   ENDOCRINE REVIEWS

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

(2019) Alexander Dimitri Miras et al.   Lancet Diabetes & Endocrinology

Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial

(2019) Dag Hofsø et al.   Lancet Diabetes & Endocrinology

Which Bariatric Procedure Is the Most Popular in the World? A Bibliometric Comparison

(2018) Zeki Ozsoy et al.   OBESITY SURGERY

Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study

(2018) Anita P. Courcoulas et al.   JAMA Surgery

Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery

(2018) Roy Taylor et al.   Cell Metabolism

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

(2017) Philip R. Schauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Second IFSO Global Registry Report 2013–2015

(2017) Richard Welbourn et al.   OBESITY SURGERY

Inequity to the Utilization of Bariatric Surgery: a Systematic Review and Meta-Analysis

(2015) Sanjit K. Bhogal et al.   OBESITY SURGERY

Very Low–Calorie Diet Mimics the Early Beneficial Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity and β-Cell Function in Type 2 Diabetic Patients

(2013) Clifton Jackness et al.   DIABETES

Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes

(2012) Geltrude Mingrone et al.   NEW ENGLAND JOURNAL OF MEDICINE